SARA UNDERWOOD: Open Payments
NPI 1922372952 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,254 in 122 payments from 15 companies in 2025. Trend: 2023 $716 · 2024 $1,760 · 2025 $2,254
Food & beverage: $2,254
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 30 | $839 |
| PFIZER INC. | 11 | $261 |
| Novo Nordisk Inc | 18 | $235 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $165 |
| Amgen Inc. | 14 | $151 |
| Otsuka America Pharmaceutical, Inc. | 7 | $135 |
| Lundbeck LLC | 5 | $95 |
| Lilly USA, LLC | 6 | $86 |
| Phathom Pharmaceuticals, Inc. | 7 | $62 |
| ABBVIE INC. | 4 | $61 |
Products named: AIRSUPRA, BREZTRI, REXULTI, NURTEC ODT, TRINTELLIX, FARXIGA, Wegovy, Ozempic.
Industry payments across AR — which companies pay providers there.
